Track topics on Twitter Track topics that are important to you
A new technology uses infrared light to produce a "bio-signature" of a blood sample and applies artificial intelligence to check for the signs of brain cancer. The research is advancing towards clinical translation and is being commercialized by ClinSpec Diagnostics Limited.
The post Blood Test to Diagnose Brain Cancer in Development appeared first on GEN - Genetic Engineering and Biotechnology News.
Original Article: Blood Test to Diagnose Brain Cancer in DevelopmentNEXT ARTICLE
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...